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a  b  s  t  r  a  c  t
Ion  pair  reverse-phase  liquid  chromatography  has  been  widely  employed  for nucleic  acid  separations.
A  wide  range  of  alternative  stationary  phases  have  been  utilised  in  conjunction  with  ion pair  reverse-
phase  chromatography,  including  totally  porous  particles,  non-porous  particles,  macroporous  particles
and  monolithic  stationary  phases.  In  this  study  we  have  utilised  superﬁcially  porous  silica  particles  in
conjunction  with  ion  pair  reverse-phase  liquid  chromatography  for the  analysis  of  nucleic acids.  We have
investigated  a range  of different  pore-sizes  and  phases  for the analysis  of  a diverse  range  of  nucleic  acids
including  oligonucleotides,  oligoribonucleotides,  phosphorothioate  oligonucleotides  and  high  molecular
weight  dsDNA  and  RNA.  The  pore  size  of the  superﬁcially  porous  silica  particles  was  shown  to  signiﬁcantly
affect  the  resolution  of  the nucleic  acids.  Optimum  separations  of small  oligonucleotides  such  as  those
generated  in  RNase  mapping  experiments  were  obtained  with  80 Å  pore  sizes  and  can  readily  be inter-
faced  with  mass  spectrometry  analysis.  Improved  resolution  of  larger  oligonucleotides  (>19  mers)  was
observed  with  pore  sizes  of 150 Å. The  optimum  resolution  for larger  dsDNA/RNA  molecules  was achieved
using  superﬁcially  porous  silica  particles  with  pore  sizes  of  400  Å.  Furthermore,  we  have utilised  150  Å
pore  size  solid-core  particles  to  separate  typical  impurities  of  a fully  phosphorothioated  oligonucleotide,
which  are  often  generated  in  the  synthesis  of  this  important  class  of  therapeutic  oligonucleotide.
©  2016  The  Authors.  Published  by  Elsevier  B.V.  This  is  an open  access  article  under  the  CC  BY  license. Introduction
.1. Ion pair reverse-phase chromatography
Ion pair reverse-phase chromatography (IP RP HPLC) has been
idely employed for nucleic acid separations [1–3]. A wide range
f reverse-phase stationary phases have been utilised for IP RP
PLC including traditional totally porous C18 particles (silica and
olymeric stationary phases) [1–5]. However, slow mass transfer
f oligonucleotides in the stationary phase limits the application
f these traditional C18 based stationary phases [6,7]. The devel-
pment of 2 m,  C18 surface, non-porous polymeric columns, in
onjunction with IP RP HPLC offers signiﬁcant advantages for the
nalysis of nucleic acids [8–11]. Rapid, high resolution separation
f nucleic acids has been achieved using these non-porous poly-
eric media. The highly mono-disperse nature of the particles
esults in the minimisation of the diffusion pathways and therefore
∗ Corresponding author. Fax: +44 114 222 7566.
E-mail address: m.dickman@shefﬁeld.ac.uk (M.J. Dickman).
ttp://dx.doi.org/10.1016/j.chroma.2016.02.057
021-9673/© 2016 The Authors. Published by Elsevier B.V. This is an open access article u(http://creativecommons.org/licenses/by/4.0/).
provides high resolution with rapid analysis times [1–3]. Further-
more, the column media are robust, being resistant to a broad range
of temperatures and pH. This has led to a wide variety of develop-
ments in the analysis of nucleic acids using IP RP HPLC, including
the sequence-independent sizing of duplex DNA [9], the analysis
of oligonucleotides and the separation and puriﬁcation of single-
stranded (ss) DNA [10,12]. However, a caveat associated with these
non-porous particles includes low capacity owing to the limited
surface area for interaction with the analyte.
The application of non-porous polymeric stationary phases has
also been extended to analyse larger RNA molecules in conjunction
with IP RP HPLC with high resolution, similar to that achieved for
larger dsDNA molecules and was  demonstrated in the develop-
ment of an assay for group I intron ribozyme activity [13]. Further
studies have utilised the rapid high resolution separation of RNA to
analyse a wide range of RNA transcripts and biological RNAs includ-
ing ribosomal RNA, mRNA and siRNAs [14–17]. More recently,
macro-porous PS-DVB resins with relatively large pore sizes have
been utilised for RNA separations [18]. Ultra-performance liquid
chromatography (UPLC) approaches using 1.7 m C18 particles
have also been employed to improve speed and resolution for short
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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sig. 1. Effect of pore size on the analysis of oligodeoxynucleotides using IP RP HPLC. 
ore  size using TEAA gradient 1. (B) 150 Å pore size using TEAA gradient 1. (C) 150 
t  260 nm.ligoribonucleotides, oligonucleotide therapeutics and the
equencing of synthetic oligoribonucleotides in conjunctionPLC analysis of oligo dT ladder (19–25 nt) on superﬁcially porous particles. (A) 80 Å
 size using TBAB gradient 2. 250 ng of oligo dT was analysed at 50 ◦C, UV detectionwith LC–MS analysis [19–21]. In addition to traditional partic-
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ange of monolithic stationary phases have also successfully been
pplied to the high resolution separation of DNA [22] and RNA
16,23]. Monolithic, poly(styrene-divinylbenzene)-based capillary
olumns have been utilised for nucleic acid separations interfaced
o mass spectrometry in conjunction with MS-compatible mobile
hases in a number of different applications [24–27].
Columns comprising superﬁcially porous particles (SPPs), also
ermed core–shell particles, solid-core particles and porous-shell
articles have been utilised in wide range of studies to analyse
iomolecules, demonstrating signiﬁcant advantages over tradi-
ional totally porous particles [28–30]. The advantages of core–shell
article columns for rapid HPLC analysis of biomolecules including
roteins and nucleic acids has been demonstrated, attributing this
mproved performance to superior mass transfer kinetics [28,29].
ore recently Biba et al., studied the performance of a number of
ore–shell particle columns in conjunction with IP RP HPLC for the
nalysis of oligonucleotides [31,32].
In this study we have utilised superﬁcially porous silica par-
icles (Accucore columns, Thermo Fisher) in conjunction with IP
P HPLC for the analysis of nucleic acids. The Accucore columns
ontain 2.6 m solid-core particles, with a porous layer of 0.5 m
ith an average particle size distribution of 1.12 (D90/D10). We  have
nvestigated a range of different pore-sizes and phases (C18, C4) for
he analysis of a diverse range of nucleic acids including oligonu-
leotides, oligoribonucleotides, phosphorothioate oligonucleotides
nd high molecular weight dsDNA and RNA.
. Materials and methods
.1. Chemicals and reagents
Triethylammonium acetate (TEAA, Sigma–Aldrich, UK). Tetra-
utylammonium bromide (TBAB, Fluka, UK). Acetonitrile and
ater (HPLC grade, Fisher Scientiﬁc, UK). 1,1,1,3,3,3,-Hexaﬂuoro-
-propanol (HFIP, Sigma–Aldrich, UK). Oligonucleotides were
ynthesised by Euroﬁns Scientiﬁc (UK). RNase A (Ambion, UK).
.2. IP RP HPLC
Mobile phases were prepared with HPLC grade solvents (Fisher
cientiﬁc, UK).
Nucleic acids were analysed by IP RP HPLC on a U3000 RSLC
PLC (Thermo Fisher, UK) with the following columns: Accucore
18 150 mm × 2.1 mm I.D. (2.6 m superﬁcially porous silica par-
icles 80 Å pore size), Accucore C18 150 mm  × 2.1 mm I.D. (2.6 m
uperﬁcially porous silica particles 150 Å pore size). The Accucore
olumns contain 2.6 m solid-core particles, with a porous layer of
.5 m with an average particle size distribution of 1.12 (D90/D10).
ccucore C4 150 mm × 4.6 mm I.D. (a research column based on
uperﬁcially porous silica 4.0 m superﬁcially porous silica parti-
les 400 Å pore size). Chromatograms were recorded using a VWD
etector at 260 nm with a 2.5 l ﬂow cell. Tubing was 100 m
.D. for ﬂow rates of 0.4 ml/min and 180 m I.D. for ﬂow rates of
.0 ml/min.
.3. IP RP HPLC mobile phases
Buffer A; 0.1 M triethylammonium acetate (TEAA) pH 7.4.
uffer B; 0.1 M TEAA, pH 7.4, 25% (v/v) acetonitrile. Buffer C;
.5 mM tetrabutylammonium bromide (TBAB). Buffer D; 2.5 mM
etrabutylammonium bromide, 80% acetonitrile. Buffer E; 20 mM
riethylammonium acetate (TEAA) pH 7.4, 80 mM 1,1,1,3,3,3,-
exaﬂuoro-2-propanol (HFIP). Buffer F; 20 mM triethylammonium
cetate (TEAA), pH 7.4, 80 mM 1,1,1,3,3,3,-hexaﬂuoro-2-propanol
HFIP) 25% (v/v) acetonitrile. Buffer G; 0.1 M triethylammonium
cetate (TEAA) pH 7, 80 mM 1,1,1,3,3,3,-hexaﬂuoro-2-propanol A 1440 (2016) 135–144 137
(HFIP). Buffer H; 0.1 M triethylammonium acetate (TEAA), pH 7.4,
80 mM 1,1,1,3,3,3,-hexaﬂuoro-2-propanol (HFIP) 25% (v/v) acetoni-
trile.
Gradient 1: HPLC buffers A and B. Linear gradient: 25–35% B in
1 min; 35–70% B in 14 min; 70–100% B in 0.1 min; 100% B for 3 min;
100–30% B in 0.4 min; 25% B for 5 min. Flow rate: 0.4 ml  min−1.
Gradient 2: HPLC buffers C and D. Linear gradient: 55% B for
1 min; 50–85% B in 14 min; 85–100% B in 0.5 min; 100% B for 3 min;
100–50% B in 1 min; 55% B for 4 min. Flow rate: 0.4 ml  min−1.
Gradient 3: HPLC buffers E and F. Linear gradient 10–30% F in
20 min, 30–90% F in 1 min; 90% F for 3 min; 90–10% F in 0.4 min;
10% F for 5 min  at a ﬂow rate of 0.4 ml  min−1.
Gradient 4: HPLC buffers E and F. Linear gradient 10–20% F
in 20 min, 20–30% F over 10 min; 30% F to 90%F in 1 min; 90% F
for 3 min; 90–10% F in 0.4 min; 10% F for 5 min  at a ﬂow rate of
100 l min−1.
Gradient 5: HPLC buffers A and B. Linear gradient: 45–50% B
in 1 min; 50–80% B in 20 min; 85% B to 100% B in 1 min; 100%
B for 2 min; 100–45% B in 0.4 min; 45% B for 4 min. Flow rate:
0.4 ml  min−1.
Gradient 6: HPLC buffers A and B. Linear gradient: 35–40% B in
1 min; 40–60% B in 10 min; 60–68% B in 5 min, 68% B to 100% B in
1 min; 100% B for 2 min; 100–35% B in 0.4 min; 30% B for 4 min.
Flow rate: 1.6 ml  min−1.
Gradient 7: HPLC buffers A and B. Linear gradient: 15–60% B
in 12 min; 60–100% B in 0.1 min; 100% B for 2 min; 100–15% B in
0.4 min; 15% B for 4 min. Flow rate: 0.4 ml  min−1.
Gradient 8: HPLC buffers A and B. Linear gradient 25–30%B in
1 min; 30–45% B 15 min; 45–100% B in 0.1 min; 100% B for 3 min;
100–25% B in 0.4 min; 25% B for 5 min. Flow rate: 0.4 ml  min−1.
Gradient 9: HPLC buffers A and B. Linear gradient 15–20% B in
1 min; 20–75% B 10 min; 75–100% B in 0.1 min; 100% B for 3 min;
100–15% B in 0.4 min; 25% B for 5 min. Flow rate: 0.4 ml  min−1.
Gradient 10: HPLC buffers E and F. Linear gradient 15–20% F in
1 min; 20–75% F 10 min; 75–100% F in 0.1 min; 100% F for 3 min;
100–15% F in 0.4 min; 25% F for 5 min. Flow rate: 0.4 ml  min−1.
Gradient 11: HPLC buffers C and D. Linear gradient 55–90% D
in 15 min; 90–100% D in 0.1 min; 100% D for 3 min; 100–55% D in
0.4 min; 55% D for 5 min. Flow rate: 0.4 ml  min−1.
Gradient 12: HPLC buffers E and F. Linear gradient 35–40% F in
1 min; 40–90% F 10 min; 90–100% F in 0.1 min; 100% F for 3 min;
100–35% F in 0.4 min; 35% F for 5 min. Flow rate: 0.4 ml  min−1.
Gradient 13: HPLC buffers C and D. Linear gradient 55–80% D
in 15 min; 85–100% D in 0.1 min; 100% D for 3 min; 100–55% D in
0.4 min; 55% D for 5 min. Flow rate: 0.4 ml  min−1.
2.4. RNase mass mapping
Following puriﬁcation, 1 g of ssRNA in RNase-free water was
incubated with 1 U RNase A at 37 ◦C for 30 min. Subsequently,
500 ng, was analysed using LC ESI MS  with an Accucore C18 col-
umn  (2.6 m superﬁcially porous silica particles 80 Å pore size
150 mm × 2.1 mm ID) and gradient 4. Mass spectrometry was per-
formed on a maXis Ultra High Resolution Time of Flight Instrument
(Bruker Daltonics) in negative ion mode with a selected mass range
of 300–2500 m/z. An ion source voltage of −2000 V and N2 source
gas temperature of 300 ◦C at 6.0 L/h was used to maintain a cap-
illary current of 30–50 nA, with nebuliser gas pressure at 0.4 bar.
A list of theoretical monoisotopic masses of oligoribonucleotides
was generated using Mongo Oligo Mass Calculator (http://rna.rega.
kuleuven.ac.be/masspec/mongo.htm). The output of this software
produces a theoretical sequence ladder of oligoribonucleotides for
the ssRNA with all possible chemical termini including; 5′-OH,
-phosphate, -cyclic phosphate and 3′-OH, -phosphate, -cyclic phos-
phate.
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oig. 2. RNase mass mapping using 80 Å pore size superﬁcially porous particles. (A)
ore  size using gradient 3. (B) LS ESI MS  analysis of RNase a mass mapping of 500 n
ligoribonucleotides are highlighted.
. Results and discussion
.1. IP RP HPLC analysis of oligonucleotides using superﬁcially
orous silica particles
To evaluate the performance and effects of pore size of the
olid-core particles for the analysis of oligonucleotides, a 2′-
eoxythymine ladder (dT 19–24) was analysed by IP RP HPLC with
riethylammnonium acetate (TEAA) as the ion pair reagent in con-
unction with C18 2.6 m solid-core particles with 80 Å and 150 Å
ore sizes (see Fig. 1A and B). The results show that the pore size
f the solid-core particles affects the resolution of the dT ladder. HPLC analysis of 7–10 mer  oligonucleotides on superﬁcially porous particles, 80 Å
A in vitro transcript. 500 ng of ssRNA was analysed using gradient 4. The identiﬁed
Typical peak widths of 0.12 min  were obtained on the 80 Å com-
pared to 0.07 min  on the 150 Å pore size solid-core particles,
demonstrating that increased resolution of the oligonucleotides
were obtained on the 150 Å pore size solid-core particles at a
ﬂow rate of 0.4 ml/min. The 80 Å shows restricted diffusion for the
oligonucleotides under these conditions, resulting in broader peaks
in comparison to the 150 Å pore size solid-core particles. These
data are consistent with those observed for the analysis of pep-
tides, where increased resolution is observed on the wider pore
sized particles [29]. Further application using the 150 Å pore size
solid-core particles was  also examined using an alternative ion
pair reagent tetrabutylammonium bromide (TBAB) which enables
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Fig. 3. Effect of pore size on the analysis of dsDNA/RNA using IP RP HPLC. IP RP HPLC chromatograms of the analysis pUC18 HaeIII digest analysed using superﬁcially porous
particles. (A) 80 Å pore size using TEAA gradient 5. (B) 150 Å pore size using TEAA gradient 5 and (C) 400 Å pore size using TEAA gradient 6. 250 ng of pUC18 HaeIII digest was
analysed at 50 ◦C, UV detection at 260 nm.  (D) IP RP HPLC chromatogram of the MS2 RNA on 400 Å pore size superﬁcially porous particles using TEAA gradient 7.50 ng MS2
RNA  was  injected and analysed at 50 ◦C UV detection at 260 nm.







































Hig. 4. IP RP HPLC analysis of a synthetic oligoribonucleotide using superﬁcially poro
t  260 nm using gradient 8.
ize-dependent separations of the oligonucleotides (see Fig. 1C).
imilar resolution was obtained to the weak ion pair reagent (TEAA)
ith the same column dimensions. The results of the oligonu-
leotide separations using the 150 Å pore size solid-core particles
emonstrate that rapid, high resolution separation of oligonu-
leotides can be achieved in a similar way to those obtained using
on-porous particles and UPLC applications.
Further analysis of smaller oligonucleotides (7–10 mers)
evealed that improved resolution was obtained on the 80 Å pore
izes in comparison to the 150 Å pore size particles, in contrast to
hat observed for the larger oligonucleotides (19–24 mers). Analysis
f the 7–10 mers was performed using the MS-compatible ion pair
olvents (20 mM TEAA + 80 mM HFIP) on the 80 Å column is shown
n Fig. 2. The separation of small oligoribonucleotides is required
or RNase mapping experiments, where large RNA biomolecules
re digested with an RNAse prior to liquid chromatography, often
nterfaced with mass spectrometry analysis [33]. The application of
18 2.6 m solid-core particles with 80 Å pore sizes was therefore
pplied to RNase mapping experiments. A 500 nt ssRNA generated
ia in vitro transcription was digested using RNase A and subse-
uently analysed using IP RP HPLC interfaced with MS  (see Fig. 2B).
ligoribonucleotides were identiﬁed by comparing their observed
nd theoretical monoisotopic masses after an in silico RNase A
igest and are highlighted in Fig. 2B.
.2. IP RP HPLC analysis of large dsDNA/RNA fragments using
uperﬁcially porous silica particles
To evaluate the separation of dsDNA using IP RP HPLC in con-
unction with superﬁcially porous silica particles, a pUC18HaeIII
igest, consisting of a range of dsDNA fragments (80–587 bp), was
nalysed. Chromatograms of the dsDNA fragments on the 80 Å
nd 150 Å, 2.6 m superﬁcially porous silica particles is shown in
ig. 3A/B. The results clearly show a signiﬁcant improvement in
he resolution of the dsDNA fragments on the 150 Å pore size solid-
ore particles in comparison to the 80 Å particles, demonstrating
hat restricted diffusion for larger MW dsDNA fragments leads to
roader peaks. Furthermore, the restricted diffusion is more signif-
cant for the larger MW dsDNA fragments compared to the smaller
W oligonucleotides previously analysed using the 80 Å particles.
owever, the separation efﬁciency achieved on the 150 Å pore sizeticles. 163 pmol of synthetic oligoribonucleotide was analysed at 50 ◦C, UV detection
solid-core particles is not as high as that typically achieved on non-
porous 2 mm PS-DVB particles [3,7]. Therefore, in an approach to
further optimise the separation of the larger dsDNA fragments and
limit the restricted diffusion observed on both the 80 Å and 150 Å
particles, a research column based on superﬁcially porous silica
(4.0 mm superﬁcially porous silica particles with 400 Å pore sizes)
was evaluated (see Fig. 3C). The chromatogram shows a signiﬁcant
enhancement in the separation of the dsDNA, achieving near base-
line separation of the 257/267 bp and 434/458 bp fragments. This
observation is consistent with previous ﬁndings that increasing the
pore size (400 Å) results in improved separation of large intact pro-
teins compared to the 80 Å and 150 Å particles [29]. However, it
should be noted that, although the separation of the larger dsDNA
fragments is improved using the 400 Å pore size particles, analy-
sis of the oligonucleotides (dT 19–24) revealed a loss in resolution
compared to the 150 Å/80 Å particles (data not shown).
The requirement for high throughput analytical tools that can
readily separate, purify and analyse ribonucleic acids (RNA) are
assuming increasing signiﬁcance with the recent discoveries of the
diverse and important roles RNA plays in biological systems. In
particular, the ability to separate and analyse large MW RNAs is chal-
lenging. However, Fig. 3D shows that the large 3569 nt RNA from
bacteriophage MS2  elutes as a narrow peak, demonstrating the high
resolution separation of RNA, similar to larger dsDNA fragments,
by rapid analysis on 4.0 mm superﬁcially porous silica particles of
400 Å pore size.
Using stationary phases with different pore sizes will alter the
available surface area and therefore affect the overall capacity of the
column, retention times and possibly the effective gradient [34].
Figs. 1–3 demonstrate the importance of selecting an appropriate
sorbent pore size for the analytes of interest.
3.3. IP RP HPLC analysis of therapeutic oligonucleotides using
superﬁcially porous silica particles
With the emergence of therapeutic oligonucleotides, including
siRNA therapeutics, RNA aptamers and antisense oligonucleotides
which are all chemically synthesized, the requirement for
high throughput, robust approaches to isolate the therapeutic
oligonucleotide from impurities such as failure sequences (typi-
cally n-1/n-2, also termed short-mers) and long-mers (typically
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Fig. 5. IP RP HPLC analysis of oligonucleotide containing a single phosphorothioate using superﬁcially porous particles 150 Å pore size. (A) Separation of oligonucleotide
phosphorothioate diastereoisomers using IP RP HPLC using the weak ion pair reagent TEAA using gradient 9. (B) IP RP HPLC chromatogram of oligonucleotide phosphorothioate
diastereoisomers using IP RHPLC using the weak ion pair reagent TEAA in conjunction with HFIP using gradient 10. (C) IP RP HPLC chromatogram of oligonucleotide
phosphorothioate diastereoisomers using the strong ion pair reagent TBAB using gradient 11. (D) IP RP HPLC chromatogram of a fully phosphorothioated oligonucleotide
using  the strong ion pair reagent TBAB using gradient 12.60 pmol of each oligonucleotide was  injected and analysed at 50 ◦C, UV detection at 260 nm.
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F impurities using superﬁcially porous particles 150 Å pore size. Overlay of fully phospho-
r nd, single phosphodiester 3′-end, single phosphodiester middle, double phosphodiester








































Oligonucleotide sequences used to represent the fully phosphorothioated oligonu-
cleotide and common related impurities, po indicates phosphodiester bond.
Oligonucleotide Sequence 5′-3′
Fully phosphorothioated ACAAAAGTCCGTGAG
Single phosphodiester 5′ ApoCAAAAGTCCGTGAG
Single phosphodiester 3′ ACAAAAGTCCGTGApoG
Single phosphodiester middle ACAAAAGpoTCCGTGAGig. 6. IP RP HPLC analysis of fully phosphorothioated oligonucleotide and related 
othioated oligonucleotide, fully phosphorothioated n-1, single phosphodiester 5′-e
′/3′-ends. 80 pmol of each oligonucleotide was injected and analysed at 50 ◦C usin
ontaining deprotecting groups) is an important analytical chal-
enge. The analysis of a typical synthetic oligonucleotide is shown
n Fig. 4, demonstrating the ability to resolve the full length
roduct (FLP) from closely related impurities using 2.6 m solid-
ore particles with 150 Å pore sizes. Therapeutic oligonucleotides
re often synthesised to incorporate diverse chemical modiﬁ-
ations to confer stability in vivo. These modiﬁcations include
′-O-methyl (2′-O-Me), O-ethyl (2′-O-ethyl), O-methoxyethyl (2′-
OE), and ﬂuorine (2′-F) substitutions as well as locked nucleic
cids (LNA) and phosphorothioate backbone modiﬁcations. This
ynthesis strategy can result in even more complex impurities,
ncluding diastereoisomers. The separation of phosphorothioate
ontaining oligonucleotides presents additional challenges due to
he presence of a large number of diastereoisomers that often
auses peak broadening and poor resolution of closely related
mpurities. The application of IP RP HPLC for the analysis of
ully phosphorothioate containing oligonucleotides has been pre-
iously studied using TEA/HFIP (typically 16 mM TEA/400 mM
FIP) in conjunction with porous C18 particles. Under these
ptimised IP conditions, predominantly size-based separations
re performed where the peak broadening effect of the dif-
erent hydrophobicities of phosphorothioate diastereoisomers is
liminated [35–37]. Further studies using cyclohexyldimethylam-
onium acetate (CycHDMAA) in conjunction with monolithic,
oly(styrene-divinylbenzene)-based capillary columns have also
een used to analyse fully phosphorothioate containing oligonu-
leotides [38].
The analysis of an oligonucleotide containing a single phospho-
othioate, using 150 Å pore size solid-core particles in conjunction
ith the weak ion pairing reagent TEAA is shown in Fig. 5A. Short
lkyl chains such as those in TEAA, allow the stationary phase to
artially retain its hydrophobic or reverse phase properties as TEAA
nly partially covers the stationary phase. Therefore, separation is
ependent on both size and base composition. The results demon-
trate the ability to rapidly separate the two diastereoisomers
RP and SP) that are present similar to previous studies utilising
lternative stationary phases [39–41]. However, analysis of fully
hosphorothioate containing oligonucleotides under weak ion pair
eagent conditions leads to the appearance of a broad peak dueDouble phosphodiester ApoCAAAAGTCCGTGApoG
n-1 CAAAAGTCCGTGAG
to the presence multiple diastereoisomers which are likely to co-
elute with various shortmer and longmer impurities. To promote
the co-elution of the phosphorothioate diastereoisomers and there-
fore reduce the peak width of fully phosphorothioate containing
oligonucleotides, the analysis was  performed in the presence of
HFIP and alternatively using strong ion pair reagent tetrabuty-
lammonium bromide (TBAB). Using TBAB the longer alkyl chains
provide complete coverage of the stationary phase and a dynamic
anion-exchange is the predominant mechanism, resulting in size
based separation with limited sequence effects. Analysis under
these conditions promotes size dependent separations and min-
imises the effects of the diastereoisomers, as shown in Fig. 5B and
C. Under these conditions the two diastereoisomers of the singly
phosphorothioated oligonucleotide co-elute and as expected the
peak width of the fully phoshorothioated oligonucleotide is sig-
niﬁcantly reduced (see Fig. 5D). Although utilising the ion pair
reagent TBAB and the addition of HFIP minimises the effects of
the diastereoisomers in fully phosphorothioate containing oligonu-
cleotides, their analysis still remains challenging as the effects are
not fully supressed. This can be seen by comparing the peak width
of the fully phosphorothioate oligonucleotide (0.17 min) and fully
phosphodiester oligonucleotide (0.11 min) of the same sequence
analysed on the same gradient slope (see Supplementary Fig. 1).
In addition, the ability to separate typical impurities generated
during the synthesis of a fully phosphorothioated oligonucleotide
was also studied. A number of common impurities including
the oxidised phosphodiester were synthesised to represent com-
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he superﬁcially porous silica particles to separate the single
hosphodiester containing oligonucleotide (5′-end, 3′-end and the
iddle), double phosphodiester oligonucleotide and n-1 trun-
ated oligonucleotide from the full length fully phosphorothioate
ligonucleotide, the analysis was performed using the previously
ptimised conditions with the strong ion pair reagent TBAB (see
ig. 6). The results demonstrate the separation of the full length
ully phosphorothioate oligonucleotide from the single/double
hosphodiester impurities and the n-1 truncated species. The abil-
ty to resolve these common impurities on superﬁcially porous
ilica particles with 150 Å pore size in conjunction with opti-
ised sequence dependent separations and cost effective solvents,
ncluding low amounts of HFIP to TEAA and strong ion pair reagents
uch as TBAB, provides a signiﬁcant development in the analysis
f therapeutic oligonucleotides including fully phosphorothioate
ligonucleotides.
. Conclusions
Superﬁcially porous silica particles enable the rapid, high res-
lution separation of nucleic acids using IP RP HPLC. The pore
izes of the C18 superﬁcially porous silica particles signiﬁcantly
ffects the resolution of the nucleic acids. Optimum separations of
mall oligonucleotides such as those generated in RNase mapping
xperiments were obtained with 80 Å pore sizes and can readily be
nterfaced with mass spectrometry analysis. Improved resolution
f larger oligonucleotides (>19 mers) was observed with pore sizes
f 150 Å. The optimum resolution for larger dsDNA/RNA molecules
as achieved using superﬁcially porous silica particles with pore
izes of 400 Å. Therefore, it is important to select the appropriate
ore sizes of the C18 superﬁcially porous silica particles prior to
nalysis of nucleic acids.
The analysis of an oligonucleotide containing a single phospho-
othioate backbone modiﬁcation, using 150 Å pore size solid-core
articles in conjunction with the weak ion pairing reagent TEAA
nabled the separation of the two diastereoisomers (RP and SP)
hat are present. The use of superﬁcially porous silica particles
n conjunction with strong ion pair reagents (TBAB) promotes
ize dependent separations and was shown to minimise the
ffects of the diastereoisomers. In addition, the ability to sepa-
ate typical impurities generated during the synthesis of a fully
hosphorothioated oligonucleotide using superﬁcially porous sil-
ca particles (150 Å pore size) was shown in conjunction with
ptimised sequence dependent separations. The results demon-
trate the ability to separate the full length fully phosphorothioate
ligonucleotide from the single/double phosphodiester impurities
nd the n-1 truncated species which are often generated in the
ynthesis of this important class of therapeutic oligonucleotide.
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